Why Is Coinbase Stock Going Down?
Every way you look at it, Coinbase has had a…
Sell
12
LABU Quote, Financials, Valuation and Earnings
Last price:
$94.05
Seasonality move
:
-9.66%
Day range:
$91.49 - $98.77
52-week range:
$80.41 - $176.99
Dividend yield:
0.6%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
2.1M
Avg. volume:
1.3M
1-year change:
-27.29%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
LABU
Direxion Daily S&P Biotech Bull 3X Shares
|
-- | -- | -- | -- | -- |
|
NUGT
Direxion Daily Gold Miners Index Bull 2X Shares
|
-- | -- | -- | -- | -- |
|
ROM
ProShares Ultra Technology
|
-- | -- | -- | -- | -- |
|
UDOW
ProShares UltraPro Dow30
|
-- | -- | -- | -- | -- |
|
UWM
ProShares Ultra Russell2000
|
-- | -- | -- | -- | -- |
|
UYG
ProShares Ultra Financials
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
LABU
Direxion Daily S&P Biotech Bull 3X Shares
|
$94.04 | -- | -- | -- | $0.15 | 0.6% | -- |
|
NUGT
Direxion Daily Gold Miners Index Bull 2X Shares
|
$35.87 | -- | -- | -- | $0.25 | 1.76% | -- |
|
ROM
ProShares Ultra Technology
|
$72.83 | -- | -- | -- | $0.03 | 0.2% | -- |
|
UDOW
ProShares UltraPro Dow30
|
$97.82 | -- | -- | -- | $0.15 | 0.92% | -- |
|
UWM
ProShares Ultra Russell2000
|
$42.42 | -- | -- | -- | $0.18 | 1.14% | -- |
|
UYG
ProShares Ultra Financials
|
$87.05 | -- | -- | -- | $0.20 | 0.5% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
LABU
Direxion Daily S&P Biotech Bull 3X Shares
|
-- | 5.522 | -- | -- |
|
NUGT
Direxion Daily Gold Miners Index Bull 2X Shares
|
-- | -1.223 | -- | -- |
|
ROM
ProShares Ultra Technology
|
-- | 2.473 | -- | -- |
|
UDOW
ProShares UltraPro Dow30
|
-- | 2.749 | -- | -- |
|
UWM
ProShares Ultra Russell2000
|
-- | 3.000 | -- | -- |
|
UYG
ProShares Ultra Financials
|
-- | 1.709 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
LABU
Direxion Daily S&P Biotech Bull 3X Shares
|
-- | -- | -- | -- | -- | -- |
|
NUGT
Direxion Daily Gold Miners Index Bull 2X Shares
|
-- | -- | -- | -- | -- | -- |
|
ROM
ProShares Ultra Technology
|
-- | -- | -- | -- | -- | -- |
|
UDOW
ProShares UltraPro Dow30
|
-- | -- | -- | -- | -- | -- |
|
UWM
ProShares Ultra Russell2000
|
-- | -- | -- | -- | -- | -- |
|
UYG
ProShares Ultra Financials
|
-- | -- | -- | -- | -- | -- |
Direxion Daily S&P Biotech Bull 3X Shares vs. Competitors
-
Which has Higher Returns LABU or NUGT?
Direxion Daily Gold Miners Index Bull 2X Shares has a net margin of -- compared to Direxion Daily S&P Biotech Bull 3X Shares's net margin of --. Direxion Daily S&P Biotech Bull 3X Shares's return on equity of -- beat Direxion Daily Gold Miners Index Bull 2X Shares's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- NUGTDirexion Daily Gold Miners Index Bull 2X Shares-- -- -- -
What do Analysts Say About LABU or NUGT?
Direxion Daily S&P Biotech Bull 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily Gold Miners Index Bull 2X Shares has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bull 3X Shares has higher upside potential than Direxion Daily Gold Miners Index Bull 2X Shares, analysts believe Direxion Daily S&P Biotech Bull 3X Shares is more attractive than Direxion Daily Gold Miners Index Bull 2X Shares.
Company Buy Ratings Hold Ratings Sell Ratings LABUDirexion Daily S&P Biotech Bull 3X Shares0 0 0 NUGTDirexion Daily Gold Miners Index Bull 2X Shares0 0 0 -
Is LABU or NUGT More Risky?
Direxion Daily S&P Biotech Bull 3X Shares has a beta of 2.860, which suggesting that the stock is 186.014% more volatile than S&P 500. In comparison Direxion Daily Gold Miners Index Bull 2X Shares has a beta of 2.359, suggesting its more volatile than the S&P 500 by 135.859%.
-
Which is a Better Dividend Stock LABU or NUGT?
Direxion Daily S&P Biotech Bull 3X Shares has a quarterly dividend of $0.15 per share corresponding to a yield of 0.6%. Direxion Daily Gold Miners Index Bull 2X Shares offers a yield of 1.76% to investors and pays a quarterly dividend of $0.25 per share. Direxion Daily S&P Biotech Bull 3X Shares pays -- of its earnings as a dividend. Direxion Daily Gold Miners Index Bull 2X Shares pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABU or NUGT?
Direxion Daily S&P Biotech Bull 3X Shares quarterly revenues are --, which are smaller than Direxion Daily Gold Miners Index Bull 2X Shares quarterly revenues of --. Direxion Daily S&P Biotech Bull 3X Shares's net income of -- is lower than Direxion Daily Gold Miners Index Bull 2X Shares's net income of --. Notably, Direxion Daily S&P Biotech Bull 3X Shares's price-to-earnings ratio is -- while Direxion Daily Gold Miners Index Bull 2X Shares's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bull 3X Shares is -- versus -- for Direxion Daily Gold Miners Index Bull 2X Shares. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- -- NUGTDirexion Daily Gold Miners Index Bull 2X Shares-- -- -- --
-
Which has Higher Returns LABU or ROM?
ProShares Ultra Technology has a net margin of -- compared to Direxion Daily S&P Biotech Bull 3X Shares's net margin of --. Direxion Daily S&P Biotech Bull 3X Shares's return on equity of -- beat ProShares Ultra Technology's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- ROMProShares Ultra Technology-- -- -- -
What do Analysts Say About LABU or ROM?
Direxion Daily S&P Biotech Bull 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand ProShares Ultra Technology has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bull 3X Shares has higher upside potential than ProShares Ultra Technology, analysts believe Direxion Daily S&P Biotech Bull 3X Shares is more attractive than ProShares Ultra Technology.
Company Buy Ratings Hold Ratings Sell Ratings LABUDirexion Daily S&P Biotech Bull 3X Shares0 0 0 ROMProShares Ultra Technology0 0 0 -
Is LABU or ROM More Risky?
Direxion Daily S&P Biotech Bull 3X Shares has a beta of 2.860, which suggesting that the stock is 186.014% more volatile than S&P 500. In comparison ProShares Ultra Technology has a beta of 2.327, suggesting its more volatile than the S&P 500 by 132.701%.
-
Which is a Better Dividend Stock LABU or ROM?
Direxion Daily S&P Biotech Bull 3X Shares has a quarterly dividend of $0.15 per share corresponding to a yield of 0.6%. ProShares Ultra Technology offers a yield of 0.2% to investors and pays a quarterly dividend of $0.03 per share. Direxion Daily S&P Biotech Bull 3X Shares pays -- of its earnings as a dividend. ProShares Ultra Technology pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABU or ROM?
Direxion Daily S&P Biotech Bull 3X Shares quarterly revenues are --, which are smaller than ProShares Ultra Technology quarterly revenues of --. Direxion Daily S&P Biotech Bull 3X Shares's net income of -- is lower than ProShares Ultra Technology's net income of --. Notably, Direxion Daily S&P Biotech Bull 3X Shares's price-to-earnings ratio is -- while ProShares Ultra Technology's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bull 3X Shares is -- versus -- for ProShares Ultra Technology. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- -- ROMProShares Ultra Technology-- -- -- --
-
Which has Higher Returns LABU or UDOW?
ProShares UltraPro Dow30 has a net margin of -- compared to Direxion Daily S&P Biotech Bull 3X Shares's net margin of --. Direxion Daily S&P Biotech Bull 3X Shares's return on equity of -- beat ProShares UltraPro Dow30's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- UDOWProShares UltraPro Dow30-- -- -- -
What do Analysts Say About LABU or UDOW?
Direxion Daily S&P Biotech Bull 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand ProShares UltraPro Dow30 has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bull 3X Shares has higher upside potential than ProShares UltraPro Dow30, analysts believe Direxion Daily S&P Biotech Bull 3X Shares is more attractive than ProShares UltraPro Dow30.
Company Buy Ratings Hold Ratings Sell Ratings LABUDirexion Daily S&P Biotech Bull 3X Shares0 0 0 UDOWProShares UltraPro Dow300 0 0 -
Is LABU or UDOW More Risky?
Direxion Daily S&P Biotech Bull 3X Shares has a beta of 2.860, which suggesting that the stock is 186.014% more volatile than S&P 500. In comparison ProShares UltraPro Dow30 has a beta of 2.907, suggesting its more volatile than the S&P 500 by 190.706%.
-
Which is a Better Dividend Stock LABU or UDOW?
Direxion Daily S&P Biotech Bull 3X Shares has a quarterly dividend of $0.15 per share corresponding to a yield of 0.6%. ProShares UltraPro Dow30 offers a yield of 0.92% to investors and pays a quarterly dividend of $0.15 per share. Direxion Daily S&P Biotech Bull 3X Shares pays -- of its earnings as a dividend. ProShares UltraPro Dow30 pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABU or UDOW?
Direxion Daily S&P Biotech Bull 3X Shares quarterly revenues are --, which are smaller than ProShares UltraPro Dow30 quarterly revenues of --. Direxion Daily S&P Biotech Bull 3X Shares's net income of -- is lower than ProShares UltraPro Dow30's net income of --. Notably, Direxion Daily S&P Biotech Bull 3X Shares's price-to-earnings ratio is -- while ProShares UltraPro Dow30's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bull 3X Shares is -- versus -- for ProShares UltraPro Dow30. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- -- UDOWProShares UltraPro Dow30-- -- -- --
-
Which has Higher Returns LABU or UWM?
ProShares Ultra Russell2000 has a net margin of -- compared to Direxion Daily S&P Biotech Bull 3X Shares's net margin of --. Direxion Daily S&P Biotech Bull 3X Shares's return on equity of -- beat ProShares Ultra Russell2000's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- UWMProShares Ultra Russell2000-- -- -- -
What do Analysts Say About LABU or UWM?
Direxion Daily S&P Biotech Bull 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand ProShares Ultra Russell2000 has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bull 3X Shares has higher upside potential than ProShares Ultra Russell2000, analysts believe Direxion Daily S&P Biotech Bull 3X Shares is more attractive than ProShares Ultra Russell2000.
Company Buy Ratings Hold Ratings Sell Ratings LABUDirexion Daily S&P Biotech Bull 3X Shares0 0 0 UWMProShares Ultra Russell20000 0 0 -
Is LABU or UWM More Risky?
Direxion Daily S&P Biotech Bull 3X Shares has a beta of 2.860, which suggesting that the stock is 186.014% more volatile than S&P 500. In comparison ProShares Ultra Russell2000 has a beta of 2.307, suggesting its more volatile than the S&P 500 by 130.719%.
-
Which is a Better Dividend Stock LABU or UWM?
Direxion Daily S&P Biotech Bull 3X Shares has a quarterly dividend of $0.15 per share corresponding to a yield of 0.6%. ProShares Ultra Russell2000 offers a yield of 1.14% to investors and pays a quarterly dividend of $0.18 per share. Direxion Daily S&P Biotech Bull 3X Shares pays -- of its earnings as a dividend. ProShares Ultra Russell2000 pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABU or UWM?
Direxion Daily S&P Biotech Bull 3X Shares quarterly revenues are --, which are smaller than ProShares Ultra Russell2000 quarterly revenues of --. Direxion Daily S&P Biotech Bull 3X Shares's net income of -- is lower than ProShares Ultra Russell2000's net income of --. Notably, Direxion Daily S&P Biotech Bull 3X Shares's price-to-earnings ratio is -- while ProShares Ultra Russell2000's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bull 3X Shares is -- versus -- for ProShares Ultra Russell2000. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- -- UWMProShares Ultra Russell2000-- -- -- --
-
Which has Higher Returns LABU or UYG?
ProShares Ultra Financials has a net margin of -- compared to Direxion Daily S&P Biotech Bull 3X Shares's net margin of --. Direxion Daily S&P Biotech Bull 3X Shares's return on equity of -- beat ProShares Ultra Financials's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- UYGProShares Ultra Financials-- -- -- -
What do Analysts Say About LABU or UYG?
Direxion Daily S&P Biotech Bull 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand ProShares Ultra Financials has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bull 3X Shares has higher upside potential than ProShares Ultra Financials, analysts believe Direxion Daily S&P Biotech Bull 3X Shares is more attractive than ProShares Ultra Financials.
Company Buy Ratings Hold Ratings Sell Ratings LABUDirexion Daily S&P Biotech Bull 3X Shares0 0 0 UYGProShares Ultra Financials0 0 0 -
Is LABU or UYG More Risky?
Direxion Daily S&P Biotech Bull 3X Shares has a beta of 2.860, which suggesting that the stock is 186.014% more volatile than S&P 500. In comparison ProShares Ultra Financials has a beta of 2.124, suggesting its more volatile than the S&P 500 by 112.388%.
-
Which is a Better Dividend Stock LABU or UYG?
Direxion Daily S&P Biotech Bull 3X Shares has a quarterly dividend of $0.15 per share corresponding to a yield of 0.6%. ProShares Ultra Financials offers a yield of 0.5% to investors and pays a quarterly dividend of $0.20 per share. Direxion Daily S&P Biotech Bull 3X Shares pays -- of its earnings as a dividend. ProShares Ultra Financials pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABU or UYG?
Direxion Daily S&P Biotech Bull 3X Shares quarterly revenues are --, which are smaller than ProShares Ultra Financials quarterly revenues of --. Direxion Daily S&P Biotech Bull 3X Shares's net income of -- is lower than ProShares Ultra Financials's net income of --. Notably, Direxion Daily S&P Biotech Bull 3X Shares's price-to-earnings ratio is -- while ProShares Ultra Financials's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bull 3X Shares is -- versus -- for ProShares Ultra Financials. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- -- UYGProShares Ultra Financials-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Uber Stock a Buy on the Dip?
Shares of Uber Technologies (NYSE:UBER) have been fading fast in…
Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
54
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
LMND alert for Dec 28
Lemonade [LMND] is down 10.69% over the past day.
Sell
50
TSLL alert for Dec 28
Direxion Daily TSLA Bull 2X Shares [TSLL] is down 9.92% over the past day.
Buy
63
SMLR alert for Dec 28
Semler Scientific [SMLR] is down 9.65% over the past day.
